Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    A blurred dark image shows the logo of a stylized sgd monogram in white against a dark background The monogram appears to be

    Sgd S.A.

    SGD Pharma is a global leader in pharmaceutical glass packaging, producing over 8 million vials and bottles daily across five ISO-certified plants in Europe and Asia.

    Company Overview

    SGD Pharma specializes in the production of molded and tubular glass packaging for the pharmaceutical industry, serving clients worldwide with high-quality vials, bottles, and ampoules. The company operates five manufacturing plants and maintains a robust global supply chain, supported by more than 90 agents and distributors. Their solutions cater to parenteral, oral, and nasal drug applications, emphasizing innovation and sustainability.

    Key Metrics

    1,200

    Import Shipments

    9

    Distribution Centers

    700.0M

    Annual Revenue

    1896

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    SGD Pharma has recently focused on expanding its tubular glass capacity, advancing sustainable manufacturing, and launching innovative packaging solutions for sensitive pharmaceuticals.

    Strategic Expansion

    Acquisition of Alphial S.r.l. to expand European tubular glass production

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    SGD Pharma delivers primary glass packaging solutions for the pharmaceutical sector, focusing on molded and tubular glass vials, bottles, and ampoules. With five state-of-the-art manufacturing plants in Europe and Asia, the company produces over 8 million units daily and maintains ISO 15378 certification for quality and compliance. Their product portfolio supports a wide range of therapeutic applications, including parenteral, oral, and nasal drugs. SGD Pharma is recognized for its commitment to innovation, sustainability, and global supply chain excellence.

    Headquarters

    Puteaux Cedex, France

    Founded

    1896

    Stock Symbol

    Private company